A migraine is more than a severe headache. It is a neurological condition involving changes in how the brain processes sensory information, regulates pain, and communicates with the nerves and blood vessels surrounding it. During an attack, networks that control these functions become unusually active or sensitive, producing symptoms that can include throbbing head pain, nausea, sensitivity to light and sound, and, in some people, temporary visual or sensory disturbances.
The process is complex, and scientists have not identified a single mechanism that explains every migraine symptom. However, research has established that migraine involves the brain’s sensory and pain-processing systems, the trigeminal nerve pathway, and chemical signals that influence nerve activity and inflammation around pain-sensitive tissues.
Understanding these mechanisms helps explain why migraine can begin before head pain develops, why ordinary light or movement can become intolerable during an attack, and why the effects may persist even after the headache subsides.
Migraine begins with altered brain activity
The brain continuously processes information from the eyes, ears, skin, internal organs, and other sensory systems. It also regulates sleep, attention, mood, and many automatic bodily functions. In people who experience migraine, certain neural networks are more susceptible to changes that can trigger an attack.
This susceptibility is partly genetic. Migraine tends to run in families, although its inheritance is complex and usually involves multiple genetic factors rather than a single gene. These factors can influence how nerve cells communicate, how readily they become activated, and how the brain responds to changes in its internal or external environment.
During a migraine attack, activity across several interconnected brain regions changes. These changes affect the processing of pain and sensory signals, as well as functions such as appetite, alertness, and nausea regulation.
Migraine is therefore not simply a reaction to pain. It is a disorder in which the nervous system enters a state that makes certain signals more likely to produce symptoms.
The attack may develop gradually, with subtle changes in concentration, mood, energy, or sensory sensitivity appearing before the headache. In some people, the attack begins with an aura, a temporary neurological disturbance that most often affects vision. In others, head pain is the first noticeable symptom.
These differences reflect the fact that migraine does not follow precisely the same sequence in every person or every attack.
How the brain’s pain pathways become activated
Although the brain itself contains no pain-sensitive nerve endings, many structures around it can detect painful stimuli. These include the meninges, the protective membranes surrounding the brain, as well as certain blood vessels and other tissues in the head.
A major pathway involved in migraine pain begins with the trigeminal nerve, a large cranial nerve that carries sensory information from the face, forehead, and parts of the head. Its branches connect with pain-sensitive tissues around the brain and relay signals to the brainstem and other regions involved in processing pain.
During a migraine attack, this trigeminal system becomes activated. Nerve endings release signaling molecules, including calcitonin gene-related peptide, commonly known as CGRP. This molecule plays an important role in migraine biology.
CGRP can widen blood vessels and influence the transmission of pain signals. It also participates in communication between nerve cells and surrounding tissues. In migraine, signaling through this pathway helps sustain the flow of pain-related information to the brain.
The importance of CGRP is supported by the effectiveness of treatments that block its activity or prevent it from binding to its receptor. These medicines can reduce migraine attacks in many people, providing strong evidence that CGRP signaling is a significant part of the disease process.
However, CGRP is not the sole cause of migraine. Other signaling molecules, neural circuits, and biological processes also contribute. The precise combination of mechanisms that initiates and sustains an attack remains an active area of research.
Why migraine pain can throb and worsen with movement
Migraine pain is often described as throbbing or pulsating, although it can also feel like steady pressure or aching. It frequently affects one side of the head, but it can occur on both sides.
The pulsating quality may partly reflect how pain-sensitive tissues and their nerve endings respond to vascular and other physiological signals. However, migraine pain cannot be explained simply by blood vessels expanding.
Earlier explanations emphasized the widening and narrowing of blood vessels as the main cause of migraine. Modern understanding places greater emphasis on the nervous system, with changes in blood vessel diameter forming only one part of a more complicated process.
Pain-sensitive tissues around the brain transmit signals through the trigeminal system, while the brain processes and regulates those signals through interconnected networks. The resulting pain depends on more than the physical state of a blood vessel.
Movement can make the pain worse because activity changes pressure and blood flow in the body and head, while also producing sensory signals that interact with an already sensitized pain system. Walking quickly, bending over, climbing stairs, or exercising may intensify the sensation.
This sensitivity to routine movement is one reason migraine differs from many ordinary tension-type headaches. During an attack, normal physical activity can amplify pain rather than distract from it.
Why light, sound, and smells can become overwhelming
One of the most disabling features of migraine is increased sensitivity to sensory input. Bright light may feel painful, ordinary sounds may become intolerably loud, and certain smells may provoke discomfort or nausea.
These symptoms are known as photophobia, phonophobia, and osmophobia, respectively. They do not necessarily mean that the eyes, ears, or nose are damaged. Instead, they reflect changes in how sensory information is processed and interacts with pain-related brain networks.
The visual system, for example, does more than form images. Signals from the eyes travel through several brain regions that help determine brightness, contrast, movement, and visual importance. Some of these pathways interact with neural circuits involved in headache pain.
During migraine, light can therefore increase discomfort even when vision itself is normal. Darkness may provide relief because it reduces the amount of visual input entering an already sensitive system.
Sound sensitivity follows a related principle. Auditory information continues to reach the brain, but the experience of that information changes. Sounds that would ordinarily be unremarkable may become distracting, irritating, or painful.
Smell sensitivity can also increase during an attack, and particular odors may aggravate symptoms or trigger nausea in some people. The relationship between odors and migraine is complicated: an odor may provoke symptoms in a susceptible person, but heightened sensitivity to smells can also be part of an attack that has already begun.
These sensory effects illustrate an important feature of migraine: the nervous system does not process each type of information in isolation. Sensory and pain pathways interact, so increased activity in one system can intensify symptoms in another.
What happens during a migraine aura
Some people experience an aura before or during the headache phase. An aura can involve visual disturbances, tingling, altered sensation, or difficulty finding words. Visual symptoms are the most common.
A typical visual aura may begin with a small area of blurred or missing vision, shimmering lines, flashing lights, or a zigzag pattern that gradually expands across part of the visual field. These effects usually develop over several minutes rather than appearing all at once.
One leading explanation is a phenomenon called cortical spreading depression, also known as cortical spreading depolarization. It involves a slowly moving wave of intense activity among nerve cells and supporting brain cells, followed by a period of reduced activity.
The wave is accompanied by changes in the movement of ions, electrically charged particles that help nerve cells generate and transmit signals. As the disturbance moves across the cerebral cortex, the brain’s outer layer responsible for many higher functions, it temporarily alters the activity of the neurons it passes.
When this process affects the visual cortex at the back of the brain, it can produce the moving patterns, flashes, or blind spots associated with visual aura. If other cortical regions are involved, symptoms may include tingling or language difficulties.
The gradual progression of many aura symptoms fits with the slow movement of this wave across the cortex. Nevertheless, not every migraine aura has been fully explained, and cortical spreading depression should not be assumed to account for every symptom in every person.
Aura and headache are also not interchangeable. Some people experience aura without a subsequent headache, while others have migraine attacks without any aura at all. When a headache follows an aura, the two may overlap in time.
New, sudden, or unusual neurological symptoms should not automatically be attributed to migraine. Stroke and other medical conditions can produce similar symptoms and may require urgent evaluation, particularly when weakness, sudden speech difficulty, or abrupt vision loss occurs.
Why nausea and digestive symptoms occur
Migraine can affect the digestive system as well as the head. Nausea is common, and some people vomit or have difficulty eating and drinking during an attack.
These symptoms arise partly from interactions between brain regions that process pain and those that regulate nausea, vomiting, and automatic bodily functions. The brainstem contains networks involved in coordinating these responses, while connections with the hypothalamus and other regions help regulate appetite and internal bodily states.
Migraine can also affect how the digestive tract functions. Some people experience changes in stomach motility, the muscular movements that move food through the stomach. In certain attacks, delayed stomach emptying may contribute to the feeling that food or oral medication is sitting uneasily in the stomach.
The relationship is not identical in everyone, and digestive symptoms can vary between attacks. Nausea may occur before the headache, become more severe as pain intensifies, or persist after the pain begins to improve.
These connections help explain why migraine is not simply a condition of the head. The same neurological disturbance can influence several systems at once, including digestion, alertness, balance, and sensory processing.
The hypothalamus and the symptoms that precede an attack
Many people notice changes hours before the headache begins. They may feel unusually tired, yawn repeatedly, crave particular foods, become irritable, struggle to concentrate, or experience changes in thirst and urination.
This early phase is called the prodrome. It can occur before migraine with or without aura, and its symptoms differ from person to person.
The hypothalamus, a small but important structure deep in the brain, helps regulate sleep, hunger, thirst, body temperature, hormones, and daily biological rhythms. It also communicates with regions involved in pain processing.
Changes in hypothalamic activity have been associated with different stages of migraine, making this structure a plausible contributor to the symptoms that precede an attack. However, the exact role it plays in initiating an individual migraine remains incompletely understood.
Prodromal symptoms also help explain why some apparent triggers can be difficult to identify. A person may crave chocolate or feel unusually tired shortly before the headache begins and conclude that the craving or fatigue caused the attack. In some cases, these changes may instead be early manifestations of a migraine process that is already underway.
This does not mean that external triggers are unimportant. Sleep disruption, stress, hormonal changes, skipped meals, and other factors can influence migraine susceptibility. Rather, the timing of symptoms can make cause and effect difficult to distinguish.
Why migraine attacks develop in phases
Migraine is often described in four possible phases: prodrome, aura, headache, and postdrome. Not everyone experiences all four, and the phases can overlap.
During the prodrome, changes in mood, energy, appetite, concentration, or sensory sensitivity may appear. If aura occurs, temporary neurological symptoms follow or overlap with this early period. The headache phase involves pain and often nausea and heightened sensitivity to light or sound. After the pain subsides, some people experience fatigue, difficulty concentrating, dizziness, or a lingering sense of mental fog. This final period is called the postdrome.
The existence of these phases reflects the distributed nature of migraine. Different networks can become involved at different times, and the symptoms of an attack do not necessarily begin or end together.
The postdrome is particularly instructive. Even after the headache improves, the person may not feel fully recovered. Pain signals may have diminished, but other changes in sensory processing, attention, and general well-being can persist.
For some people, the full episode disrupts much more time than the period of intense head pain alone. This is one reason migraine’s effects on daily life can be substantial even when the headache itself lasts only part of the overall attack.
What makes someone susceptible to migraine
Migraine susceptibility reflects an interaction between inherited biology and environmental influences. Genetics can affect the excitability of nerve cells, the regulation of sensory networks, and the body’s responses to physiological changes.
This does not mean that a person with migraine has a permanently abnormal brain. Rather, their nervous system may be more vulnerable to entering a state in which ordinary signals produce disproportionate symptoms.
Potential triggers include inadequate or irregular sleep, skipped meals, dehydration, stress, changes in caffeine intake, hormonal fluctuations, and certain sensory conditions. Individual patterns vary considerably. A factor that precedes attacks in one person may have little effect on another, and the same factor may not trigger an attack every time.
Stress illustrates this complexity. An attack may occur during a demanding period, but it can also begin when stress eases. Changes in routine, sleep, and physiological arousal may all contribute, and the exact combination differs among individuals.
Hormonal fluctuations are particularly relevant for many people who menstruate. Changes in estrogen levels can influence migraine susceptibility, although the underlying mechanisms involve more than a single hormone or a simple rise or fall in its concentration.
A trigger is best understood as a factor that can help push a susceptible nervous system toward an attack, not necessarily as the sole cause. Migraine can occur without an identifiable trigger, and having a particular trigger does not guarantee that an attack will follow.
How migraine treatments act on the brain and its pain pathways
Migraine treatments work at different points in the biological processes involved in an attack. Some aim to stop an attack after it begins; others reduce the likelihood that attacks will occur.
Acute treatments include medications that target the trigeminal pain pathway. Triptans, for example, act on serotonin receptors and can reduce migraine pain and associated symptoms in many people. They influence signaling in pathways involved in headache and can reduce the release of certain pain-related molecules. Because they also constrict blood vessels, they are not appropriate for everyone.
Newer treatments can target CGRP or its receptor, interrupting a signaling pathway that contributes to migraine. Depending on the medication, these treatments can be used to treat attacks or help prevent them.
Other acute options include certain anti-inflammatory medicines, which reduce pain and inflammation-related signaling, and medications for nausea. The most suitable treatment depends on the person’s medical history, symptoms, attack pattern, and other medications.
Preventive treatments take a different approach. They aim to make attacks less frequent, less severe, or shorter. Several types of medication can help, and some treatments specifically target CGRP signaling. The mechanisms of other preventive therapies vary, but many appear to influence the excitability of neural networks or the processing of pain signals.
Nonmedication measures can also support migraine management. Regular sleep, consistent meals, adequate fluid intake, physical activity as tolerated, and attention to individual patterns may reduce vulnerability for some people. These measures do not eliminate the biological basis of migraine, and they are not substitutes for appropriate treatment when attacks are disabling.
Frequent use of acute headache medication can itself contribute to medication-overuse headache in susceptible people. Anyone who regularly needs rescue medication or whose headaches are becoming more frequent should discuss a treatment plan with a health care professional.
What scientists still do not fully understand
Despite major advances in migraine research, several questions remain unresolved. Scientists do not yet know precisely what initiates every attack, why one person develops aura while another does not, or why symptoms can vary so widely from one episode to the next.
It is also difficult to identify a single event that explains the entire attack. Migraine involves interacting systems, and the relative contribution of each system may change over time. A mechanism that is important during aura may not be the main driver of pain later in the episode.
The role of blood vessels is a useful example of how scientific understanding has developed. Vascular changes are involved in migraine, but they do not adequately explain the condition on their own. Evidence from neural physiology and the success of treatments targeting specific signaling pathways show that migraine must be understood as a disorder of nervous-system function.
The most useful current model is therefore a network-based one: a susceptible brain enters a changing physiological state, sensory and pain pathways become more responsive, signaling molecules help transmit and sustain symptoms, and multiple brain regions contribute to the experience of an attack.
This model explains why migraine can affect vision, digestion, concentration, mood, and sensitivity to the environment, sometimes before head pain begins and sometimes after it ends. It also explains why migraine is a genuine neurological disorder rather than simply an unusually painful headache.